YKYung Jee Kang

Yung Jee Kang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yung Jee Kang has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Nayeon Choi

    Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    6 shared publications
  • Sung Yool Park

    Department of Otorhinolaryngology‐Head and Neck Surgery Inje University, College of Medicine, Busan Paik Hospital Busan Korea

    3 shared publications
  • Eun-Jae Chung

    Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

    2 shared publications
  • Han-Sin Jeong

    Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    2 shared publications
  • Sang Duk Hong

    Department of Otorhinolaryngology‐Head and Neck Surgery Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Republic of Korea

    2 shared publications
  • Soon-Hyun Ahn

    Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

    2 shared publications

Latest Publications

  • Open Access

    Prognostic Comparison of Long-Term Outcomes and Nodal Recurrence for Persistent and Recurrent Differentiated Thyroid Cancer

    by Yung Jee Kang, Ji-Hoon Kim, Ji Ye Lee, Sun Wook Cho, Young Joo Park, Kyu-Eun Lee, Su-Jin Kim, Hanaro Park, Sung Joon Park, Soon-Hyun Ahn, et al.

    Objectives. Differentiated thyroid cancer (DTC) has a favorable prognosis. However, indeterminate lymph nodes (LNs) are common, making it challenging to distinguish recurrent from persistent DTC. Previous studies have not specifically compared the prognosis between recurrent and persistent DTC. Therefore, we aimed to compare prognosis and oncologic characteristics between these two groups.Methods. This retrospective cohort study was conducted at a single tertiary care institution and included 265 patients with DTC (recurrent, 109; persistent, 156) who underwent reoperation between November 1, 1999, and August 31, 2018, for structural disease. Patients with distant metastasis at the time of initial diagnosis were excluded. Clinical and oncological characteristics, patterns of LN metastasis, disease-free survival (DFS), and overall survival (OS) were compared between the two groups. For DFS, time zero was defined as the date of the second operation.Results. Recurrent DTC had a higher incidence of central LN metastasis (P=0.003), infield recurrence (P<0.001), and distant metastasis (P<0.001). In contrast, persistent DTC more frequently exhibited lateral LN metastasis (P=0.003) and outfield recurrence (P<0.001). The most common site of neck LN metastasis was ipsilateral level VI/VII (51.4%) in recurrent DTC and ipsilateral level IV (43.0%) in persistent DTC. Ten-year DFS was significantly lower in recurrent DTC than in persistent DTC (41.0% vs. 67.9%; P<0.001). Recurrent DTC, older age, a higher number of metastatic LNs at the second operation (first reoperation), and R1/R2 resection at the second operation were associated with decreased DFS. OS did not significantly differ between recurrent and persistent DTC (P=0.160).Conclusion. Recurrent DTC is associated with poorer DFS than persistent DTC, although OS does not significantly differ between the two groups.


  • Open Access

    Sternothyroid Muscle Dystonia as an Unusual Cause of Dysphonia: A Case Report and Review of Diagnostic and Therapeutic Strategies

    by Yung Jee Kang, Tack-Kyun Kwon

    The causes of dysphonia are diverse. When bilateral vocal fold motion is normal and there are no mucosal lesions, conditions such as muscle tension dysphonia (MTD) and neurologic disorders should be considered in the differential diagnosis. To our knowledge, no prior reports have described sternothyroid muscle dystonia as a cause of dysphonia. We present a case of a 58-yearold female diagnosed with sternothyroid muscle dystonia. Her voice changes developed without any notable medical or social history. Laryngoscopic examination revealed no mucosal abnormalities or vocal fold immobility, except for vocal fold bowing, and her voice was unusually low in pitch for her age and sex. Notably, a downward movement of the larynx during phonation was observed without corresponding movement of the hyoid bone. Initial treatments—including voice therapy to rule out MTD and injection laryngoplasty for vocal fold atrophy—were unsuccessful. Suspecting sternothyroid muscle dystonia, botulinum toxin A was injected into the muscle, resulting in voice improvement. With repeated injections, followed by surgical division of the muscle, further subjective voice improvement was observed. Focal muscle dystonia affecting the voice is rare, and dystonia of the sternothyroid muscle has not previously been described. This case suggests that sternothyroid muscle dystonia may be an underrecognized cause of dysphonia. Furthermore, it may be effectively treated with botulinum toxin A injections and surgical intervention in patients whose larynx descends during phonation. We aim to introduce sternothyroid muscle dystonia as a novel etiology of dysphonia and describe its potential treatment options.

  • Open Access

    Clinical Risk Factor for Detected Distant Metastasis and Anaplastic Transformation After Reoperation in Recurrent/Persistent Differentiated Thyroid Cancer: A Retrospective Cohort Study

    by Min‐Su Kim, Yung Jee Kang, Soon‐Hyun Ahn, Sun‐Wook Cho, Young‐Joo Park, Su‐Jin Kim, Kyu‐Eun Lee, Eun‐Jae Chung

    Objectives: Research on detected distant metastasis or anaplastic transformation in recurrent/persistent differentiated thyroid cancer is limited. We analyzed the clinical factors associated with detected distant metastasis or anaplastic transformation following reoperation for differentiated thyroid cancer.Methods: This retrospective review included 336 patients who underwent reoperation for differentiated thyroid cancer with detection of distant metastasis or anaplastic transformation following reoperation. The hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated.Results: Distant metastasis was detected in 45 patients (45/336, 13.4%) after reoperation. The risk of distant metastasis was higher for patients of male sex (adjusted HR: 2.373; 95% CI: 1.133–4.973), age ≥ 55 (adjusted HR: 4.991; 95% CI: 2.451–10.165), initial T3‐4 stage (adjusted HR: 2.347; 95% CI: 1.035–5.321), in‐field recurrence (adjusted HR: 3.267; 95% CI: 1.489–7.168), and those who had undergone ≥ 3 reoperations (adjusted HR: 3.378; 95% CI: 1.248–9.174). Anaplastic transformation was detected in 7 patients (7/336, 2.1%) after reoperation. The risk of anaplastic transformation was higher for patients with an age ≥ 55 (adjusted HR: 6.811; 95% CI: 1.300–35.676) and those who had undergone ≥ 3 reoperations (adjusted HR: 5.672; 95% CI: 1.139–28.236).Conclusion: In recurrent/persistent differentiated thyroid cancer, distant metastasis or anaplastic transformation following reoperation is not insignificant. There may be increased risk of distant metastasis or anaplastic transformation with multiple reoperations in patients who are men, aged ≥ 55, or at the initial T3–T4 stage.Level of Evidence: 4.


  • Open Access

    Changing Trends of Thyroid Cancer Clinical Characteristics and Treatment Pattern in South Korea: Insights from an Institutional Database and the Korean Cancer Center Registry Database

    by Yung Jee Kang, Nayeon Choi, Jungirl Seok, Sun Wook Kim, Tae-Hyuk Kim, Jae Hoon Chung, Young-Ik Son, Man Ki Chung

    Yung Jee Kang, Nayeon Choi, Jungirl Seok, Sun Wook Kim, Tae-Hyuk Kim, Jae Hoon Chung, Young-Ik Son and Man Ki Chung. Int J Thyroidol 2024;17:277-85. https://doi.org/10.11106/ijt.2024.17.2.277


  • Open Access

    A Case of Facial Nerve Schwannoma Presenting as a Rapidly Growing Parotid Gland Tumor

    by Sung Yool Park, Yung Jee Kang, Gangmi Kim, Nayeon Choi

    임상이비인후과(Journal of Clinical Otolaryngology Head and Neck Surgery)


  • Voice Disorders and Hearing Loss May Be Additive Risk Factors for Depression in a National Cohort

    by Anaïs Rameau, Lauren H. Tucker, Michael W. Denham, Yung Jee Kang, Nayeon Choi, Mark Lachs, Tony Ehren Rosen, Michael Stewart, Sara Czaja, Justin S. Golub

    Objectives: Hearing loss (HL) (receptive communication impairment) is a known risk factor for depression. However, dysphonia (expressive communication impairment), has received little study. We study HL, self‐reported voice disorder, and combined impairment as risk factors for depression in a large national cohort.Methods: This was a cross‐sectional epidemiologic study. Data were analyzed from the Korean National Health and Nutrition Examination Survey (KNHANES) cycles 2008–2012 and 2019–2020. KNHANES uniquely contains both audiometry and voice disorder data. HL (yes/no) was defined as ≥25 dB pure tone average. Voice disorder (yes/no) was defined by self‐report. Depression (yes/no) was defined by physician diagnosis. Odds ratios for depression were calculated using multivariable logistic regressions with HL and voice disorder.Results: 8,524 individuals aged 19 to 80 years old had complete data. The mean age was 57.3 years (SD = 13.4) and 64% were women. All regressions were controlled for age and sex. Those with HL, versus those without, had 1.27 times the odds (95% CI = 1.07–1.52, p = 0.007) of depression. Those with self‐reported voice disorder, versus those without, had 1.48 times the odds (1.22–1.78, p < 0.001) of depression. Those with HL and self‐reported voice disorder, versus those with neither, had 1.79 times the odds (1.27–2.48, p < 0.001) of depression.Conclusions: This study demonstrates independent relationships between HL and depression and self‐reported voice disorder and depression. Combined HL and self‐reported voice disorder had nearly 1.8 times the odds of depression. This is likely due to the grossly additive effect of difficulty with incoming and outgoing communication streams.Level of Evidence: II Laryngoscope, 134:4060–4065, 2024


  • Open Access

    A Modified Approach for Preventing Anterior Glottic Web Formation Using Mitomycin C in Bilateral Vocal Fold Lesions

    by Yung Jee Kang, Sung Yool Park, Gangmi Kim, Ye-Jin Suh, Jason Yun, Nayeon Choi, Young-Ik Son

    Objectives: Laryngeal keel insertion, mucosal suture, application of mitomycin-C (MMC), and staged operations are approaches to prevent the anterior glottic web, but there are limitations. Our study suggests a modified approach to prevent the formation of an anterior glottic web. Methods: This retrospective single-institution tertiary center study (N = 23) involved the simultaneous removal of bilateral vocal fold lesions with topical MMC application. If exudate was identified after 4 to 6 weeks, second laryngomicroscopic surgery (LMS) was performed to remove it with topical MMC application. Extent of anterior glottic web was measured as a percentage of the total length of the membranous vocal fold. Results: After the initial surgery, 18 patients recovered without anterior web or fibrin exudate. Thick exudate was observed in 5 patients. After the second LMS, all patients showed improvement and did not develop anterior web. Conclusion: This modified method has been developed to prevent the anterior glottic web without complications.


  • Open Access

    Extra-Capsular Spread of Lymph Node Metastasis in Oral, Oropharyngeal and Hypopharyngeal Cancer: A Comparative Subsite Analysis

    by Yung Jee Kang, Goeun Park, Sung Yool Park, Taehwan Kim, Eunhye Kim, Yujin Heo, Changhee Lee, Han-Sin Jeong

    Background: The extra-capsular spread (ECS) of lymph node metastasis (LNM) is a hallmark of aggressive primary tumor phenotype in head and neck cancer (HNC); however, the factors influencing ECS are poorly understood. Patients and Methods: This was a retrospective study, including 190 cases of oral tongue cancer (OTC), 148 cases of oropharyngeal cancer (OPC) (118 HPV-positive and 30 HPV-negative), and 100 cases of hypopharyngeal cancer (HPC). Tumor dimension, tumor biological variables (lymphovascular/perineural invasion and histologic grade), and LNM variables (LNM number and size) were analyzed according to the presence of ECS using multivariable logistic regression and receiver operating characteristic (ROC) curve analyses. Results: LNM variables were significant factors for ECS in all subsites of HNC (p < 0.05), except HPV-positive OPC. In OTC, tumor dimensional variables were significantly related to ECS (p < 0.01). Meanwhile, in OPC and HPC, neither the primary tumor dimension nor the T status were significant factors for ECS occurrence. The predictability of ECS by ROC curve using multiple variables was 0.819 [95% confidence interval: 0.759–0.878] in OTC, 0.687 [0.559–0.815] in HPV-positive OPC, 0.823 [0.642–1.000] in HPV-negative OPC, and 0.907 [0.841–0.973] in HPC. Conclusion: LNM variables were correlated with ECS occurrence for most HNC subsites, and site-dependent primary tumor characteristics might contribute differentially to the ECS development of LNM in HNC.


  • Open Access

    Olfactory Rehabilitation in Total Laryngectomy Patients

    by Yung Jee Kang, Nayeon Choi

    Patients who undergo total laryngectomy often experience difficulties with their voice, olfaction, and taste due to the lack of airflow through nasal and oral cavities. While voice rehabilitation is more commonly performed, olfactory rehabilitation has gained importance in recent times with the use of various techniques. Previous studies have shown that incidence of hyposmia or anosmia (partial or total loss of smell) after total laryngectomy ranges from 25% to 100%. However, after olfactory rehabilitation, there has been notable improvement in olfaction, ranging from 46% to 88% of the patients. There are two main techniques for olfactory rehabilitation. The first involves creating airflow for smelling purposes by connecting the oral or nasal cavity to the tracheostoma using prosthetic laryngeal bypass devices. The second technique involves orofacial musculature training, which includes a nasal airflow-inducing maneuver known as the “polite yawning technique.” This maneuver creates negative pressure in the oropharynx, resulting in the induction of nasal airflow and potentially improving olfaction. Additionally, rehabilitation through biofeedback can facilitate airflow in the nasal cavity, further enhancing the sense of smell. In this review, we will introduce the principles, pathogenesis, and various techniques of olfactory rehabilitation, as well as summarize the outcomes of olfactory rehabilitation efforts.